biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > What are the thoughts….

<< Previous

Bullboard Posts

Next >>

Post by ronrydellon May 31, 2023 11:24am

173 Views

Post# 35472563

What are the thoughts….

...of the posters on this board as to how the month of June, 2023 and the rest of the summer will go?
Will the continued (are they stil continuing) of discussions with the appropriate Pharmas going to save us from bankruptcy? Are they still looking at x3b as a vehicle to save and possibly grow the firm over the short and long term?

<< Previous

Bullboard Posts

Next >>

Covalon Technologies posts third profitable quarter in a row